Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Long-Term Effects of Repeated Cycles of Intrathecal Triamcinolone Acetonide on Spasticity in MS Patients.
Orthopaedic Management of Spasticity.
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.
Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies.
Management of Multiple Sclerosis in the Breastfeeding Mother.
Recurrent paraparesis and death of a patient with 'whippet' abuse.
MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy.
Enriched CD161high CCR6+ γδ T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis.
Increased IL-17A but Decreased IL-27 Serum Levels in Patients with Multiple Sclerosis.
Cuprizone-Induced Demyelination as a Tool to Study Remyelination and Axonal Protection.
Further evidence for the neuroprotective role of oleanolic acid in a model of focal brain hypoxia in rats.
MAL Overexpression Leads to Disturbed Expression of Genes That Influence Cytoskeletal Organization and Differentiation of Schwann Cells.
Hyperinsulinemia in newly diagnosed patients with multiple sclerosis.
Extending Treatment Up To Eight Weeks With Infusion Medication Shown Safe and Effective in Patients with Multiple Sclerosis
Dopaminergic D2-like agonists produce yawning in the myelin mutant taiep and Sprague-Dawley rats.
Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery.
Developing and implementing lifestyle management programs© with people with multiple sclerosis.
Standing Data Disproves Biomechanical Mechanism for Balance-Based Torso-Weighting.
Baseline Retinal Nerve Fiber Layer Thickness and Macular Volume Quantified by OCT in the North American Phase 3 Fingolimod Trial for Relapsing-Remitting Multiple Sclerosis.
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.
Anti-Interferon Beta Antibody Titers Strongly Correlate Between Two Bioassays and In Vivo Biomarker Expression, and Indicates That a Titer of 150 TRU/mL Is a Biologically Functional Cut-Point.
Acrolein-mediated conduction loss is partially restored by potassium channel blockers.
Options in improving respiratory function in multiple sclerosis.
Management of multiple sclerosis.
Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the Nationwide Inpatient Sample.
Pages
« first
‹ previous
…
506
507
508
509
510
511
512
513
514
…
next ›
last »